Pharyngitis Market Forecast for Incremental CAGR Growth by 2026

Rockville, US, 2018-Feb-01 — /EPR Network/ — A sore throat or pharyngitis is caused when a virus infects the area of the throat. Some of the most common causes of pharyngitis is viral infections such as the influenza and common cold. Acute pharyngitis is one of the most common condition, hence, there has been an increase in demand for systematic treatment and medication. Drug manufacturers are also focusing on research and development of new drugs to treat pharyngitis without causing any side-effects. This Fact.MR report analyzes the expansion of global pharyngitis market till date, and provides key insights on the growth of the market during the forecast period, 2017-2026.

Request For Sample Report @https://www.factmr.com/connectus/sample?flag=S&rep_id=361

The report offers an overview of the global pharyngitis market. This comprises an introduction to the market, along with a standard definition of the product – pharyngitis. In this section, market value and year-over-year growth is offered to the readers. Year-over-year growth provides readers with a broader view of growth patterns over the forecast period.

The report’s succeeding section focuses on drivers, restraints and key trends from macroeconomic, demand, and supply perspectives. Impact analysis of weighted average model-based growth drivers is contained in the report for better provision of decision-making insights to clients.

In order to offer readers with up-to-date information about the latest advancements in the global pharyngitis market, the report provides updates about market opportunities, which can benefit leading manufacturers of pharyngitis. With continuous evolution of the healthcare sector, keeping a record of latest developments and trends is fundamental for pharyngitis manufacturers to formulate key business strategies. Detailed insights about raw material sourcing, supply chain, regulatory approvals, pricing analysis, list of distributors, and cost structure are provided in this section.

5 Forecast Highlights on Global Pharyngitis Market

1. Asia Pacific Excluding Japan (APEJ) is expected to remain dominant in the global pharyngitis market during the forecast period. Group A Streptococcus is a most common disease caused in settings of poverty, where transmission of an organism is possible due to the poor living condition. Hence, APEJ presents an opportunity for drug manufacturers. Moreover, the presence of key drug manufacturers in the region is also resulting in the growth of the market.
2. North America is also expected to witness growth in the coming years. As the cigarette smoking is very common among young adults and is significantly associated with sore throat. Moreover, there has been an increase in the cases of acute pharyngitis diagnosed in children in the U.S.
3. Beta lactams is expected to be one of the highly preferred drug class in the global pharyngitis market. By the end of 2026, beta lactams is estimated to reach close to US$ 500 million revenue.
4. Retail pharmacies and drug stores are expected to witness the highest growth during the forecast period 2017-2026. Retail pharmacies and drug stores are estimated to exceed US$ 600 million revenue towards the end of 2026.
5. Oral drug delivery is expected to be the most preferred drug administration route as it is convenient and also costs the least. Accounting for more than half of the revenue share, oral drug delivery is estimated to exceed US$ 1,200 million revenue by the end of 2026.

Oral Drug Delivery to Gain Maximum Traction between 2017 and 2026

Oral drug delivery is likely to emerge as the most-preferred drug administration route. Oral drug delivery is projected to create an incremental opportunity of over US$ 300 million between 2017 and 2026. Owing to the cost-effectiveness, convenience and high patient compliance, oral drug delivery is witnessing significant growth. However, many drugs are poorly bioavailable when administered. Hence, lipid-based drug delivery system is one of the emerging trends addressing bioavailability challenges. Moreover, oral drug delivery is the least invasive method as compared to other routes. Targeted drug delivery is also an emerging trend, in which the drug is active only in the targeted area.

Browse Full Report with TOC @https://www.factmr.com/report/361/pharyngitis-market

Competition Tracking

The report also profiles companies that are expected to remain active in the expansion of global pharyngitis market through 2026, which include Pfizer Inc., GlaxoSmithKline PLC, Novartis AG, BioStar Pharmaceuticals, Inc., and Zambon Group SpA.

Check Discount @https://www.factmr.com/connectus/sample?flag=D&rep_id=361

About Fact.MR       
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/